SEC 13F Intelligence

CRISPR THERAPEUTICS AG

CUSIP 033408113

Crispr Therapeutics AG has 1 institutional holders in Filings Flow’s 13F database, together reporting 17.6K shares worth $801,133 as of Q3 2023.

Institutional Holders
1
Q3 2023
Reported Value
$801,133
Ticker
unmapped
private placement or foreign
Quarters Tracked
11

Ownership Trend

Institutional holders
Q2 ’19: 1Q2 ’19Q3 ’19: 1Q4 ’19: 1Q4 ’19Q1 ’20: 1Q2 ’20: 1Q2 ’20Q3 ’20: 1Q4 ’20: 1Q4 ’20Q4 ’21: 1Q1 ’23: 1Q1 ’23Q2 ’23: 1Q3 ’23: 1Q3 ’23filingsflow.com
Total reported value
Q2 ’19: $2MQ2 ’19Q3 ’19: $2MQ4 ’19: $2MQ4 ’19Q1 ’20: $2MQ2 ’20: $3MQ2 ’20Q3 ’20: $3MQ4 ’20: $3MQ4 ’20Q4 ’21: $101,000Q1 ’23: $581,205Q1 ’23Q2 ’23: $990,871Q3 ’23: $801,133Q3 ’23filingsflow.com

Holders

··
Export to Excel
Manager% of PortfolioValueSharesQuarter
Value Star Asset Management (Hong Kong) Ltd$49M AUM0.28%$801,13317.6KQ3 2023

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.